Downstream of Endoglin, Smad1 and the master hematopoietic regulator Scl (stem cell leukemia) were identified to mediate the observed effects of CD105 on BL-CFC and their erythroid/endothelial potential [91]. This evidence concerns the gene ENG and acute leukemia.